Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lynch

Showing results (881-890 of 929) with videos related to

Pageof 93
Sort By:
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
JAMA|July 13, 2006
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 MutationAmy Finch, Mario Beiner, Jan Lubinski, et al.
Breast Cancer Research : BCR|October 22, 2009
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.
Neuroscience Letters|March 17, 1999
Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutationsH Houlden, P Rizzu, M Stevens, et al.
American Journal of Human Genetics|April 16, 2003
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndromeE E M Jaeger, K L Woodford-Richens, M Lockett, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Breast Cancer Research and Treatment|October 19, 2013
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutationAdriana Valentini, Jan Lubinski, Tomasz Byrski, et al.
Journal of Medicinal Chemistry|May 22, 2026
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical EvaluationJames M Smith, Bernard Barlaam, David Beattie, et al.
Journal of Medical Genetics|December 14, 1999
Familial gastric cancer: overview and guidelines for managementC Caldas, F Carneiro, H T Lynch, et al.
Pageof 93

Showing results (881-890 of 929) with videos related to

Sort By:
Pageof 93
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
JAMA|July 13, 2006
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 MutationAmy Finch, Mario Beiner, Jan Lubinski, et al.
Breast Cancer Research : BCR|October 22, 2009
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen, Sean Brummel, Yuan Chun Ding, et al.
Neuroscience Letters|March 17, 1999
Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutationsH Houlden, P Rizzu, M Stevens, et al.
American Journal of Human Genetics|April 16, 2003
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndromeE E M Jaeger, K L Woodford-Richens, M Lockett, et al.
Cancer Causes & Control : CCC|July 29, 2005
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Breast Cancer Research and Treatment|October 19, 2013
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutationAdriana Valentini, Jan Lubinski, Tomasz Byrski, et al.
Journal of Medicinal Chemistry|May 22, 2026
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical EvaluationJames M Smith, Bernard Barlaam, David Beattie, et al.
Journal of Medical Genetics|December 14, 1999
Familial gastric cancer: overview and guidelines for managementC Caldas, F Carneiro, H T Lynch, et al.
Pageof 93